This issue of ""Emerging Cancer Therapeutics"" provides a comprehensive review for practitioners on the current status of lymphoma subtypes. ""Lymphoma"" includes: Expert contributors from across the US and Canada; multidisciplinary coverage and emphasis on emerging therapeutic options, cutting edge developments and clinical research with near-term potential in clinical management. ""Emerging Cancer Therapeutics"" is an invited review publication providing a thorough analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence; current clinical best practice, and likely near future developments. There is an emphasis throughout on multidisciplinary approaches to the specialty, as well as on quality and outcomes analysis. Published three times a year, ""Emerging Cancer Therapeutics"" provides authoritative, thorough assessments of advances in therapeutics in all major areas of oncology, both solid and hematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact and encompassing new technologies with implications for management such as molecular imaging.
"synopsis" may belong to another edition of this title.
Arnab Chakravarti, MD, Chair and Professor, Department of Radiation Oncology Max Morehouse Chair of Cancer Research, Co-Director, Brain Tumour Program, Arthur G. James Comprehensive Cancer Centre and Richard L. Solove Research Institute, The Ohio State University Medical School
Martin Fuss, MD, Professor and Vice Chair, Director Program in Image-guided Radiation Therapy, Department of Radiation Medicine, Oregon Health & Science University
Charles R. Thomas, MD, Professor and Chairman, Department of Radiation Medicine, Oregon Health and Science University
"About this title" may belong to another edition of this title.
Seller: suffolkbooks, Center moriches, NY, U.S.A.
hardcover. Condition: Very Good. Fast Shipping - Safe and Secure 7 days a week! Seller Inventory # 3TWDDA003NHW
Seller: BOOKWEST, Phoenix, AZ, U.S.A.
Hardcover. Condition: New. 1st Edition. SHRINK-WRAPPED: US SELLER SHIPS FROM USA. Seller Inventory # ORD7-S0-HC-1936287781-2P3-B6-MC-2012
Seller: Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, United Kingdom
Condition: As New. Seller Inventory # 096487-1
Quantity: 1 available
Seller: Basi6 International, Irving, TX, U.S.A.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEOCT25-230369
Seller: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Seller Inventory # ABBB-51700
Seller: SMASS Sellers, IRVING, TX, U.S.A.
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. Seller Inventory # SNTA-51700
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 208. Seller Inventory # 2642980168
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. pp. 208. Seller Inventory # 49835159
Quantity: 1 available
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 1st edition. 144 pages. 10.00x7.25x0.50 inches. In Stock. Seller Inventory # zk1936287781
Quantity: 1 available
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condition: new. Hardcover. This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of lymphoma subtypes. Lymphoma includes: Details the most current management across the spectrum of lymphoma subtypes Expert contributors from across the US and Canada Multidisciplinary coverage and emphasis on emerging therapeutic options, cutting edge developments and clinical research with near-term potential in clinical management Series Description: Emerging Cancer Therapeutics is an invited review publication providing a thorough analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence; current clinical best practice, and likely near future developments. There is an emphasis throughout on multidisciplinary approaches to the speciality, as well as on quality and outcomes analysis. Published three times a year, Emerging Cancer Therapeutics provides authoritative, thorough assessments of advances in therapeutics in all major areas of oncology, both solid and haematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact and encompassing new technologies with implications for management such as molecular imaging. This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of lymphoma subtypes. It includes details the most current management across the spectrum of lymphoma subtypes; expert contributors from across the US and Canada; and multidisciplinary coverage and emphasis on emerging therapeutic options, cutting edge developments and clinical. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9781936287789